Skip to content
Screener

OraSure Technologies OSUR Income (Loss) from Continuing Operations before Equity Method Investments, Net of Tax

Income (Loss) from Continuing Operations before Equity Method Investments, Net of Tax at other companies

Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-$116.33M-56.2%
ICU Medical logo
ICU MedicalICUI
$480.25K+102%
ICU Medical logo
ICU MedicalICUI
$480.25K+102%
Mid-America Apartment Communities logo
Mid-America Apartment CommunitiesMAA
$126.35M-32.1%
United States Antimony logo
United States AntimonyUAMY
$166.8K-8.1%
United States Antimony logo
United States AntimonyUAMY
$166.8K-8.1%

Other financials

Income statement

See full
Revenue$30.6M-1.9%
Gross profit$13.3M+1.2%
Operating income$5.4M+130%
Net income$6.2M+132%
EPS (diluted)$0.09+135%

Balance sheet

See full
Cash & equivalents$160.6M-31.5%
Total debt$12.1M-14.4%
Total equity$317.8M-16.5%
Total assets$360.6M-19.0%

Cash flow

See full
Operating cash flow-$9.9M+3.0%
CapEx$2.4M+25.4%
Free cash flow-$12.3M-1.6%

Valuation

See full
Market cap$278.84M+36.6%
Enterprise value$130.35M-895%
P/S2.5×+1.0×

Profitability

See full
Gross margin42.6%+2.1pp
Operating margin-48.1%+14.2pp
Net margin-43.7%+10.0pp
FCF margin-42.8%-85.7pp

Returns & leverage

See full
Return on equity-14.1%+1.8pp
Debt / equity0.0×
Current ratio8.9×+1.8×

Where this comes from

Reported directly by OraSure Technologies in its filing.

Tagged under the XBRL concept osur:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNetOfTax.

The source filing: OraSure Technologies’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001116463-26-000052
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
OTHER INCOME1,3771,1352,9252,913
Income (loss) before income taxes and equity investment6,817(16,891)(14,904)(32,863)
INCOME TAX EXPENSE (BENEFIT)552,000(377)1,544
INCOME (LOSS) BEFORE EQUITY INVESTMENT6,762(18,891)(14,527)(34,407)
LOSS ON EQUITY INVESTMENT(513)(802)(1,601)(1,326)
NET INCOME (LOSS)$6,249$(19,693)$(16,128)$(35,733)
EARNINGS (LOSS) PER SHARE
BASIC$0.09$(0.26)$(0.23)$(0.48)

Item 1. FINANCIAL STATEMENTS

FAQ

What is OraSure Technologies's income (loss) from continuing operations before equity method investments, net of tax?
OraSure Technologies (OSUR) reported income (loss) from continuing operations before equity method investments, net of tax of $6.76M in Q2 2026.
How has OraSure Technologies's income (loss) from continuing operations before equity method investments, net of tax changed year-over-year?
OraSure Technologies's income (loss) from continuing operations before equity method investments, net of tax increased by 135.8% year-over-year, from -$18.89M to $6.76M.
What is the long-term trend for OraSure Technologies's income (loss) from continuing operations before equity method investments, net of tax?
Over 2 years (2023 to 2025), OraSure Technologies's income (loss) from continuing operations before equity method investments, net of tax has grown at a 11.2% compound annual growth rate (CAGR), from $53.66M to -$66.39M.
What does income (loss) from continuing operations before equity method investments, net of tax mean?
Income (Loss) from Continuing Operations before Equity Method Investments, Net of Tax as reported by OraSure Technologies Inc.

Ask your AI about OraSure Technologies's income (loss) from continuing operations before equity method investments, net of tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude